Dr Reddy’s And Hikma Win Big On US Vascepa Patents

Hikma Considering At-Risk Launch If Originator Appeals

 
• By Dean Rudge
  
Gavel
The district court's decision could be fruitful for Dr Reddy's and Hikma • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin